CVE-2026-67558: fallo de gravedad alta en Quanovate Tech Inc. (operating as Mira / Mira…
Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing
Publicada el · Actualizada el
Aviso por correo cuando entre en el KEV, tenga PoC pública o suba de nota.
21Vexday Risk Score
Sin señal de explotación. Ningún artefacto público de explotación conocido hasta ahora.
ssvc Trackcvss 8.2epss 0.3%
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:A/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N
Productos afectados
Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Android AppQuanovate Tech Inc. (operating as Mira / Mira Care) · Mira FirmwareCVEs relacionadas — Quanovate Tech Inc. (operating as Mira / Mira…
En el mismo producto, de las más peligrosas a las menos.
CVE-2026-68067CRITICALMira Hormone Monitor, Mira Android App Weak AuthenticationEPSS 0.5%CVE-2026-67568CRITICALMira Hormone Monitor, Mira Android App Use of Hard-coded CredentialsEPSS 0.4%CVE-2026-66875HIGHMira Hormone Monitor, Mira Android App Missing authentication for critical functionEPSS 0.4%CVE-2026-66340MEDIUMMira Hormone Monitor, Mira Android App Improper restriction of excessive authentication attemptsEPSS 0.4%CVE-2026-66832MEDIUMMira Hormone Monitor, Mira Android App Use of GET request method with sensitive query stringsEPSS 0.4%CVE-2026-66098HIGHMira Hormone Monitor, Mira Android App Missing authentication for critical functionEPSS 0.3%